This book explains the importance and practice of pediatric drug testing for pharmaceutical and toxicology professionals. It describes the practical and ethical issues regarding non-clinical testing to meet US FDA Guidelines, differences resulting from the new European EMEA legislation, and how to d
Pediatric Nonclinical Drug Testing: Principles, Requirements, and Practices
- Year
- 2012
- Tongue
- English
- Leaves
- 354
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
This book explains the importance and practice of pediatric drug testing for pharmaceutical and toxicology professionals. It describes the practical and ethical issues regarding non-clinical testing to meet US FDA Guidelines, differences resulting from the new European EMEA legislation, and how to develop appropriate information for submission to both agencies. It also provides practical study designs and approaches that can be used to meet international requirements. Covering the full scope of non-clinical testing, regulations, models, practice, and relation to clinical trials, this text offers a comprehensive and up-to-date resource.Content:
Chapter 1 Introduction (pages 1β27): Elise M. Lewis, Luc M. De Schaepdrijver and Timothy P. Coogan
Chapter 2 Overview of Pediatric Diseases and Clinical Considerations on Developing Medicines for Children (pages 29β39): Bert Suys and Jose Ramet
Chapter 3 Nonclinical Safety Assessment for Biopharmaceuticals: Challenges and Strategies for Juvenile Animal Testing (pages 41β57): Timothy P. Coogan
Chapter 4 FDA Approach to Pediatric Testing (pages 59β77): Robert E. Osterberg
Chapter 5 Pediatric Drug Development Plans (pages 79β92): Kimberly C. Brannen and Beatriz Silva Lima
Chapter 6 Application of Principles of Nonclinical Pediatric Drug Testing to the Hazard Evaluation of Environmental Contaminants (pages 93β113): Susan L. Makris
Chapter 7 Nonclinical Testing ProceduresβPharmacokinetics (pages 115β127): Loeckie L. de Zwart, Johan G. Monbaliu and Pieter P. Annaert
Chapter 8 Preclinical Development of a Pharmaceutical Product for Children (pages 129β139): Graham P. Bailey, Timothy P. Coogan and Luc M. De Schaepdrijver
Chapter 9 Juvenile Toxicity Study Design for the Rodent and Rabbit (pages 141β182): Alan M. Hoberman and John F. Barnett
Chapter 10 Dog Juvenile Toxicity (pages 183β212): Keith Robinson, Susan Y. Smith and Andre Viau
Chapter 11 Use of the Swine Pediatric Model (pages 213β229): Paul C. Barrow
Chapter 12 Juvenile Immunodevelopment in Minipigs (pages 231β254): Andre H. Penninks, Geertje J. D. van Mierlo, Frieke Kuper, Cor J. Snel, Niels?Christian Ganderup and Andre P. M. Wolterbeek
Chapter 13 Use of Primate Pediatric Model (pages 255β279): Gerhard F. Weinbauer, Gary J. Chellman, Allan Dahl Rasmussen and Elvira Vogelwedde
Chapter 14 Approaches to Rat Juvenile Toxicity Studies and Case Studies: a Pharmaceutical Perspective (pages 281β299): Susan B. Laffan and Lorraine Posobiec
π SIMILAR VOLUMES
Authoritative, comprehensive, and practical, this second edition covers the infectious diseases of childhood and is organized by syndrome as well as organism. Written by the premier authorities on the subject, it contains a wealth of pertinent information and has been called the best, most useful te
Pediatric Psychopharmacology: Principles and Practice is an authoritative and comprehensive text on the use of medication in the treatment of children and adolescents with serious neuropsychiatric disorders. This benchmark volume consists of 56 chapters written by internationally recognized leader
<em>Pediatric Psychopharmacology: Principles and Practice</em> is an authoritative and comprehensive text on the use of medication in the treatment of children and adolescents with serious neuropsychiatric disorders. This benchmark volume consists of 56 chapters written by internationally recogniz